Literature DB >> 9216106

Immunoperoxidase for the detection of antibodies in cerebrospinal fluid in neurocysticercosis: use of Cysticercus cellulosae and Cysticercus longicollis particles fixed on microscopy slides.

A P de Andrade1, A J Vaz, P M Nakamura, V S Palou, R A da Cunha, A W Ferreira.   

Abstract

The ORF strain of Cysticercus longicollis represents an important model for the study of heterologous antigens in the immunodiagnosis of neurocysticcreosis (NC). The immunoperoxidase (IP) technique was standardized using a particulate antigen suspension of Cysticercus longicollis (Cl) and Cysitcercus cellulosae (Cc). Cerebrospinal fluid (CSF) samples were incubated on the antigen fixed to microscopy slides; the conjugate employed was anti-IgG-peroxidase and the enzymatic reaction was started by covering the slides with chromogen solution (diaminobenzidine/H2O2). After washing with distilled water, the slide was stained with 2% malachite green in water. Of the CSF samples from 21 patients with NC, 19 (90.5%) were positive, whereas the 8 CSF samples from the control group (100%) were negative. The results of the [P-C] test applied to 127 CSF samples from patients with suspected NC showed 28.3% reactivity as opposed to 29.1% for the IP-Cc test. The agreement index for the IP test (Cl x Cc) was 94.2%, with no significant difference between the two antigens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9216106     DOI: 10.1590/s0036-46651996000400004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  2 in total

1.  Are alternative sources of parasitic (cysticercal) antigens necessary for diagnosis of neurocysticercosis?

Authors:  M K Katti
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples.

Authors:  E C Bueno; A J Vaz; L D Machado; J A Livramento; S R Mielle
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.